FDA Approved: VYVANSE — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved Vyvanse (lisdexamfetamine dimesylate) from Takeda as an original drug application (NDA 208510). It is approved for the treatment of attention-d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

ORIG AP for VYVANSE (LISDEXAMFETAMINE DIMESYLATE)